Several lines of evidence now argue strongly that a successful HIV vaccine does not need to block infection completely. It has to mimic what already occurs in a minority of unvaccinated individuals--namely, rapid clearance of infection or reduction of viral load to a level that does not produce symptoms or permit transmission to others. The various vaccine candidates are reviewed.
No takes yet. Share an insight, caveat, or question.
Margaret I. Johnston (1997) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: